JORDEN DAVID EMERSON 13D/13G Filings for Nuo Therapeutics, Inc. (AURX)

JORDEN DAVID EMERSON 13D and 13G filings for Nuo Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-07-05
08:01 am
Purchase
2020-10-05 13D Nuo Therapeutics, Inc.
AURX
JORDEN DAVID EMERSON 2,809,740
8.900%
2,809,740increase
(New Position)
Filing